Jacobs Levy Equity Management, Inc Black Diamond Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.66 - $5.61 $65,845 - $138,869	-24,754 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.18 - $8.48 $128,225 - $209,913	24,754 New	24,754 $132,000
Q1 2021 May 17, 2021	SELL	$22.23 - $34.75 $306,796 - $479,584	-13,801 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $406,715 - $483,035	13,801 New	13,801 $442,000

119

48.1M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $82.5M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.